Market Overview:
The global tuberculin market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of tuberculosis (TB) and rising demand for tuberculin products for human and animal use. Based on type, the global tuberculin market is segmented into PPD-S, PPD RT23, and others. The PPD-S segment is expected to account for the largest share of the global tuberculin market in 2018. This can be attributed to its high accuracy and reliability in diagnosing TB infection. Based on application, the human use segment is expected to account for the largest share of the global tuberculin market in 2018. This can be attributed to increasing awareness about TB among people across all age groups and regions worldwide coupled with rising incidence of TB cases globally.
Product Definition:
A protein preparation made from the tubercle bacilli, used to determine if a person is infected with tuberculosis.
PPD-S:
PD-1 is a member of the PD-L1 family, which are type I interferons. They are produced by cells of the immune system in response to virus infection and play an important role in initiating and maintaining the antiviral state. The drug works by blocking PD-1 that blocks T cell activation, leading to reduced production of cytokines such as IFN gamma.
The global PPD-S market was valued at USD 683 million in 2016.
PPD RT23:
PPD RT23 is a rapid test used for detection of active TB. It is also known as PPD skin test or PPD antigenic response test. This method can detect latent tuberculosis infection (LTBI) in the body as well, which may give a false-negative result if performed on another species such as cats and dogs. The sensitivity of this method to detect LTBI varies with different studies; typically it ranges from 60% to 90%.
Application Insights:
The human use segment held the largest market share of over 80% in 2017. Tuberculin has been used for the treatment of latent tuberculosis infection (LTBI) and active tuberculosis since its introduction. It is also being studied as a potential therapy for drug-resistant TB, which affects approximately 10-15% of all patients suffering from TB worldwide.
The animal use segment is expected to witness significant growth during the forecast period owing to increasing usage in cattle and swine animals across various regions including North America and Europe. The presence of PPD antigen that promotes protective immunity against bovine tuberculosis makes it an attractive vaccine candidate for livestock producers globally. However, availability of cheaper vaccines with better efficacy has restrained demand from this application segment over recent years.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, availability of advanced technology and favorable government initiatives are some factors responsible for its large share. In addition, increasing prevalence of Mycobacterium tuberculosis is also expected to drive the regional market over the forecast period. For instance, according to CDC data published in MMWR Weekly (2017), from 2011 to 2015, approximately 9 million people were diagnosed with active TB and 1.1 million died due to it in U.S., representing a fatality rate of 2%.
Asia Pacific is expected to be one of the fastest-growing regions during the forecast years owing her growing population base coupled with rising incidence rates for infectious diseases such as tuberculosis.
Growth Factors:
- Increasing incidence of tuberculosis (TB) across the globe
- Growing awareness about the early diagnosis and treatment of TB
- Rising demand for rapid diagnostic tests for TB
- Proliferation of novel drug therapies and vaccines for TB treatment and prevention
- Expansion of global healthcare infrastructure
Scope Of The Report
Report Attributes
Report Details
Report Title
Tuberculin Market Research Report
By Type
PPD-S, PPD RT23, Others
By Application
Human Use, Animal Use
By Companies
SSI, Sanofi Pasteur, Zoetis, Thermo Fisher (Prionics), Par Sterile, Japan BCG Laboratory
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
247
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Tuberculin Market Report Segments:
The global Tuberculin market is segmented on the basis of:
Types
PPD-S, PPD RT23, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Human Use, Animal Use
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- SSI
- Sanofi Pasteur
- Zoetis
- Thermo Fisher (Prionics)
- Par Sterile
- Japan BCG Laboratory
Highlights of The Tuberculin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- PPD-S
- PPD RT23
- Others
- By Application:
- Human Use
- Animal Use
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Tuberculin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Tuberculin is a vaccine that helps protect people from tuberculosis (TB). Tuberculin is given as a shot in the arm.
Some of the major companies in the tuberculin market are SSI, Sanofi Pasteur, Zoetis, Thermo Fisher (Prionics), Par Sterile, Japan BCG Laboratory.
The tuberculin market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Tuberculin Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Tuberculin Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Tuberculin Market - Supply Chain
4.5. Global Tuberculin Market Forecast
4.5.1. Tuberculin Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Tuberculin Market Size (000 Units) and Y-o-Y Growth
4.5.3. Tuberculin Market Absolute $ Opportunity
5. Global Tuberculin Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Tuberculin Market Size and Volume Forecast by Type
5.3.1. PPD-S
5.3.2. PPD RT23
5.3.3. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Tuberculin Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Tuberculin Market Size and Volume Forecast by Application
6.3.1. Human Use
6.3.2. Animal Use
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Tuberculin Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Tuberculin Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Tuberculin Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Tuberculin Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Tuberculin Demand Share Forecast, 2019-2026
9. North America Tuberculin Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Tuberculin Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Tuberculin Market Size and Volume Forecast by Application
9.4.1. Human Use
9.4.2. Animal Use
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Tuberculin Market Size and Volume Forecast by Type
9.7.1. PPD-S
9.7.2. PPD RT23
9.7.3. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Tuberculin Demand Share Forecast, 2019-2026
10. Latin America Tuberculin Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Tuberculin Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Tuberculin Market Size and Volume Forecast by Application
10.4.1. Human Use
10.4.2. Animal Use
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Tuberculin Market Size and Volume Forecast by Type
10.7.1. PPD-S
10.7.2. PPD RT23
10.7.3. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Tuberculin Demand Share Forecast, 2019-2026
11. Europe Tuberculin Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Tuberculin Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Tuberculin Market Size and Volume Forecast by Application
11.4.1. Human Use
11.4.2. Animal Use
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Tuberculin Market Size and Volume Forecast by Type
11.7.1. PPD-S
11.7.2. PPD RT23
11.7.3. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Tuberculin Demand Share, 2019-2026
12. Asia Pacific Tuberculin Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Tuberculin Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Tuberculin Market Size and Volume Forecast by Application
12.4.1. Human Use
12.4.2. Animal Use
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Tuberculin Market Size and Volume Forecast by Type
12.7.1. PPD-S
12.7.2. PPD RT23
12.7.3. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Tuberculin Demand Share, 2019-2026
13. Middle East & Africa Tuberculin Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Tuberculin Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Tuberculin Market Size and Volume Forecast by Application
13.4.1. Human Use
13.4.2. Animal Use
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Tuberculin Market Size and Volume Forecast by Type
13.7.1. PPD-S
13.7.2. PPD RT23
13.7.3. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Tuberculin Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Tuberculin Market: Market Share Analysis
14.2. Tuberculin Distributors and Customers
14.3. Tuberculin Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. SSI
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Sanofi Pasteur
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Zoetis
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Thermo Fisher (Prionics)
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Par Sterile
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Japan BCG Laboratory
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook